Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Incidence of brainstem toxicity following high-dose conformal PT for adult skull-base malignancies.

13/07/2022
/ Publications

This study by the Jacksonville group reported the incidence of brainstem toxicity after proton therapy. 163 patients with skull base chordoma or chondrosarcoma...

Pencil-beam scanning proton therapy for the treatment of glomus jugulare tumours.

13/08/2022
/ Publications
/
IMPT
Pencil Beam Scanning - PBS

This study by the group from Prague, Czech Republic, reported early outcomes of 12 patients with glomus jugulare tumours (GJT) treated with IMPT to a median...

Treating head and neck cancer with proton therapy

30/12/2020
/ White Paper
/
Toxicity
IMRT
Dosimetry

Proton particles do not deposit exit dose, which allows proton therapy to spare normal tissues distal to the tumor target. This is particularly useful for...

Proton Therapy for Head and Neck Cancer: Selection and management

14/09/2022
/ Webinar

During ISOP 2022, Brandon Gunn presented the webinar "Proton Therapy for Head and Neck Cancer: Selection and management". Watch the webinar above.

Proton and carbon ion beam treatment with active raster scanning method in 147 patients with skull base chordoma at the Heidelberg Ion Beam Therapy Center-a single-center experience.

15/11/2022
/ Publications
/
Survival

This study from the Heidelberg group compared the results of 111 skull-base chordoma patients treated with carbon ion of 66 GyRBE and 36 patients treated with...

Particle beam therapy for nasopharyngeal cancer: A systematic review and meta-analysis.

15/11/2022
/ Publications
/
Survival

This is a systematic review on particle beam including proton and carbon ion therapy for primary or recurrent nasopharyngeal cancer (NPC). Twenty-six eligible...

Outcomes and Toxicities of Nonmedullary Thyroid Tumors Treated with Proton Beam Radiation Therapy.

15/11/2022
/ Publications
/
Survival

This retrospective study evaluated 22 patients with thyroid cancer treated with PBT to a total dose of 60 GyRBE adjuvantly and 70 GyRBE for gross disease. With...

Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.

12/01/2023
/ Publications

Published in JAMA Network Open, this retrospective study included 292 patients with nonmetastatic oropharyngeal cancer (OPC) of which 272 [93%] were HPV...

Intensity modulated proton therapy for early-stage glottic cancer: high-precision approach to laryngeal function preservation with exceptional treatment tolerability.

12/01/2023
/ Publications

This study reported outcomes of 15 patients with T1-2N0 glottic cancer treated to a total dose 70 Gy. The one- and two-year OS and metastases-free survival were...

A Prospective Study of Mucosal Sparing Radiation Therapy in Resected Oropharyngeal Cancer Patients.

16/01/2023
/ Publications

This study reported results of 61 patients with HPV-positive oropharyngeal cancer treated with mucosal sparing radiation therapy. 44 (72%) patients were treated...